Having watched a loved one pass away from dementia, I completely understand why this would be worth considering, especially in older populations if clear benefits emerge
Read the report to explore: Deal trends in obesity including deal stage, key drivers and barriers Deal volume by modality, targets and RoA Changes in the treatment landscape as innovation shifts to combination therapies The investment opportunity as venture dollars continue to pour into the GLP-1 market
Always consult with your healthcare providers before restarting
Trina Wilcox: That's really promising, and that sounds like it's really beneficial
Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request
As such, we cover GLP-1 drugs for members who meet prior authorization requirements for the treatment of diabetes